tiprankstipranks
Trending News
More News >
Krishna Institute of Medical Sciences Limited (IN:KIMS)
:KIMS
India Market

Krishna Institute of Medical Sciences Limited (KIMS) Stock Statistics & Valuation Metrics

Compare
0 Followers

Total Valuation

Krishna Institute of Medical Sciences Limited has a market cap or net worth of ₹269.71B. The enterprise value is ₹242.67B.
Market Cap₹269.71B
Enterprise Value₹242.67B

Share Statistics

Krishna Institute of Medical Sciences Limited has 400,138,950 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding400,138,950
Owned by Insiders
Owned by Institutions0.05%

Financial Efficiency

Krishna Institute of Medical Sciences Limited’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 29.68%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)29.68%
Return on Capital Employed (ROCE)0.42
Revenue Per Employee
Profits Per Employee
Employee Count
Asset Turnover0.65
Inventory Turnover20.54

Valuation Ratios

The current PE Ratio of Krishna Institute of Medical Sciences Limited is 52.73. Krishna Institute of Medical Sciences Limited’s PEG ratio is -6.72.
PE Ratio52.73
PS Ratio
PB Ratio8.94
Price to Fair Value8.94
Price to FCF-129.54
Price to Operating Cash Flow31.39
PEG Ratio-6.72

Income Statement

In the last 12 months, Krishna Institute of Medical Sciences Limited had revenue of 24.98B and earned 3.10B in profits. Earnings per share was 7.75.
Revenue24.98B
Gross Profit14.82B
Operating Income14.33B
Pretax Income4.60B
Net Income3.10B
EBITDA6.53B
Earnings Per Share (EPS)7.75

Cash Flow

In the last 12 months, operating cash flow was 1.36B and capital expenditures 0.00, giving a free cash flow of 1.36B billion.
Operating Cash Flow1.36B
Free Cash Flow1.36B
Free Cash Flow per Share3.40

Dividends & Yields

Krishna Institute of Medical Sciences Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta0.66
52-Week Price Change65.93%
50-Day Moving Average588.14
200-Day Moving Average553.20
Relative Strength Index (RSI)63.85
Average Volume (3m)25.12K

Important Dates

Krishna Institute of Medical Sciences Limited upcoming earnings date is May 15, 2025, TBA Not Confirmed.
Last Earnings DateFeb 6, 2025
Next Earnings DateMay 15, 2025
Ex-Dividend Date

Financial Position

Krishna Institute of Medical Sciences Limited as a current ratio of 1.21, with Debt / Equity ratio of 89.03%
Current Ratio1.21
Quick Ratio1.10
Debt to Market Cap0.06
Net Debt to EBITDA2.00
Interest Coverage Ratio26.26

Taxes

In the past 12 months, Krishna Institute of Medical Sciences Limited has paid 1.24B in taxes.
Income Tax1.24B
Effective Tax Rate0.27

Enterprise Valuation

Krishna Institute of Medical Sciences Limited EV to EBITDA ratio is 27.06, with an EV/FCF ratio of -139.90.
EV to Sales7.07
EV to EBITDA27.06
EV to Free Cash Flow-139.90
EV to Operating Cash Flow33.90

Balance Sheet

Krishna Institute of Medical Sciences Limited has ₹1.32B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of -₹1.32B billion.
Cash & Marketable Securities₹1.32B
Total Debt₹0.00
Net Cash-₹1.32B
Net Cash Per Share-₹3.30
Tangible Book Value Per Share₹43.00

Margins

Gross margin is 68.43%, with operating margin of 57.36%, and net profit margin of 12.42%.
Gross Margin68.43%
Operating Margin57.36%
Pretax Margin18.40%
Net Profit Margin12.42%
EBITDA Margin26.12%
EBIT Margin20.26%

Analyst Forecast

The average price target for Krishna Institute of Medical Sciences Limited is ₹645.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target₹645.00
Price Target Upside25.84% Upside
Analyst ConsensusModerate Buy
Analyst Count3
Revenue Growth Forecast
EPS Growth Forecast

Scores

Smart ScoreN/A
AI Score
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis